Navigation Links
Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer
Date:5/20/2013

WOBURN, Mass., May 20, 2013 /PRNewswire/ -- Flexion Therapeutics, Inc. today announced the addition of Frederick W. Driscoll to its management team as chief financial officer. Mr. Driscoll has more than 30 years of financial management experience with biotechnology and medical device companies.

Prior to joining Flexion, Mr. Driscoll was chief financial officer for Novavax (NASDAQ: NVAX) where he led a team that secured more than $250 million through a combination of investment funding and commercial and government contracts. He was also instrumental in increasing Novavax' institutional shareholder base, expanding analyst coverage and implementing numerous financial reforms that strengthened that company's position. Prior to Novavax, Mr. Driscoll served as chief financial officer and subsequently chief executive officer of publicly-traded Genelabs, chief financial officer of private company Astraris and chief executive officer of OXiGENE.

"We are delighted to add a leader of Fred's experience and expertise to our team as we continue to focus on increasing investor value while advancing our pipeline of sustained release, intra-articular osteoarthritis medicines," said Michael Clayman , M.D., chief executive officer of Flexion. "With Phase 2b data for our lead compound on the horizon, we are confident that Fred will play an important role in the future of the company."

Mr. Driscoll holds a bachelor's degree in accounting and finance from Bentley University in Waltham, Mass.

About Flexion TherapeuticsFlexion is a clinical-stage specialty pharmaceutical company developing innovative therapeutics for musculoskeletal disorders. In our efforts to provide products with superior efficacy and safety,
'/>"/>

SOURCE Flexion Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
6. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
7. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
8. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
9. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
10. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
11. Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... DryLet, ... as animal waste reduction, bioremediation, wastewater treatment, aquaculture and grease, fat and ... that it will be showcasing, ManureMagic™, its industry-leading product for animal waste ...
(Date:7/3/2015)... WIEN , July 3, ... Tiedemiehet voivat hakea verkossa osoitteessa  ... for Open Innovation in Science" ... Ludwig Boltzmann Gesellschaftin (LBG) tekemän, ... tutkimuksen mukaan terveystieteiden kaksi suurinta ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Alexander Group, a ... service industries alike-- typically known for its consummate professionalism-- embarks each year in ... and break from their day jobs. , "Our motto has always been work ...
(Date:7/3/2015)... ... July 03, 2015 , ... The global failure analysis market ... 2015 to 2020. The bioscience market is expected to grow at the highest CAGR ... failure analysis equipment in the research labs and academic institutions for root cause analysis ...
Breaking Biology Technology:DryLet to Highlight Benefits of Patented ManureMagic™ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3The Alexander Group Declares Their Independence with a Bit of Levity 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5
... May 15 Sigma-Aldrich Corporation,(Nasdaq: SIAL ) will ... May 21st at 10:45 AM GMT in London - ... live audio broadcast over the,Internet available at http://ir.sigmaaldrich.com ... file. For the webcast on, http://ir.sigmaaldrich.com users will ...
... FRANCISCO, May 15 Nile Therapeutics, Inc.,(Nasdaq: NLTX ), ... 2008., Net operating loss for the first quarter of ... million, or $0.05 per share, for the,first quarter of 2007. ... 2007 were 24.1 million and 13.8 million, respectively., Nile ...
... Clinical Pain Program for ... Ketotransdel(TM), ... TDLP), a specialty,pharmaceutical company focused on the development and commercialization of,non-invasive ... of its common stock and warrants., The Company issued 1,818,180 ...
Cached Biology Technology:Nile Therapeutics Reports 2008 First Quarter Financial Results 2Nile Therapeutics Reports 2008 First Quarter Financial Results 3Transdel Pharmaceuticals Closes $4 Million Financing 2Transdel Pharmaceuticals Closes $4 Million Financing 3
(Date:6/16/2015)... June 16, 2015 Fingerprint Cards (FPC) ... that it will amount to at least 340 MSEK to ... the rapid increase in market growth and orders received the ... guidance that revenue for 2015 will exceed 1,500 MSEK to ... approximately 2,200 MSEK. Due to receipt of orders ...
(Date:6/12/2015)... , June 12, 2015  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... patent to electronically capture, analyze and identify participants ... recognition methods. This system can: ... an enrollment and subsequent sign-on process is actually ...
(Date:6/9/2015)... , June 09, 2015 Research and ... of the "Gesture Recognition & Touchless Sensing ... Electronics, Automotive, & Others), Product (Biometric & Sanitary ... 2020" report to their offering. ... is expected to reach $ 23.55 Billion by ...
Breaking Biology News(10 mins):Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020 2
... fat intake seem to influence negatively the sleep pattern in ... presented on Tuesday at SLEEP 2008, the 22nd Annual Meeting ... authored by Cibele Crispim, of the Federal University of Sao ... years of age, whose food intake was analyzed by a ...
... it was black as night. It was May 19, 1780 ... at hand. Accounts of that day, which became known as ... candlelight, night birds coming out to sing, flowers folding their ... has been solved by researchers at the University of Missouri ...
... scientists at the University of Copenhagen has studied human remains ... the iron age, and discovered a man who appears to ... were as genetically diverse 2000 years ago as they are ... was previously thought. The findings also suggest that people in ...
Cached Biology News:Fat intake negatively influences the sleep pattern in healthy adults 2Mystery of infamous 'New England Dark Day' solved by tree rings 2New research refutes myth of pure Scandinavian race 2New research refutes myth of pure Scandinavian race 3